Abstract
Huiling Liu, Ruozheng Wang
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
10.1016/s1470-2045(14)71207-0 · 2015
Novel biomarkers that assist in accurate discrimination of squamous cell carcinoma from adenocarcinoma of the lung
10.1186/s12885-016-2792-1 · 2016
Cancer in Canada: Stage at diagnosis
2018
What’s new in non-small cell lung cancer for pathologists the importance of accurate subtyping, EGFR mutations and ALK rearrangements
10.1097/pat.0b013e328342629d · 2011
The lymph node status and histologic subtypes influenced the effect of postoperative radiotherapy on patients with N2 positive IIIA non-small cell lung cancer
10.1002/jso.25308 · 2019
A machine learning-based prediction of the micropapillary/solid growth pattern in invasive lung adenocarcinoma with radiomics
10.21037/tlcr-21-44 · 2021
The Indicative Value of Serum Tumor Markers for Metastasis and Stage of Non-Small Cell Lung Cancer
10.3390/cancers14205064 · 2022
Improved differentiation between primary lung cancer and pulmonary metastasis by combining dual-energy CT–derived biomarkers with conventional CT attenuation
10.1007/s00330-020-07195-9 · 2021
Radiomics and deep learning in lung cancer
10.1007/s00066-020-01625-9 · 2020
Radiomics and radiogenomics in lung cancer: A review for the clinician
10.1016/j.lungcan.2017.10.015 · 2018
Radiomic signature as a diagnostic factor for histologic subtype classification of non-small cell lung cancer
10.1007/s00330-017-5221-1 · 2018
Non-invasive classification of non-small cell lung cancer: a comparison between random forest models utilising radiomic and semantic features
10.1259/bjr.20190159 · 2019
Development of a Radiomics Prediction Model for Histological Type Diagnosis in Solitary Pulmonary Nodules: The Combination of CT and FDG PET
2020
Texture Analysis on [18F]FDG PET/CT in Non-Small-Cell Lung Cancer: Correlations Between PET Features, CT Features, and Histological Types
10.1007/s11307-019-01336-3 · 2019
A Machine-Learning Approach Using PET-Based Radiomics to Predict the Histological Subtypes of Lung Cancer
10.1097/rlu.0000000000002810 · 2019
Correlations Study Between 18F-FDG PET/CT Metabolic Parameters Predicting Epidermal Growth Factor Receptor Mutation Status and Prognosis in Lung Adenocarcinoma
2019
Optimal standardized uptake value threshold for auto contouring of gross tumor volume using positron emission tomography/computed tomography in patients with operable nonsmall-cell lung cancer: Comparison with pathological tumor size
10.4103/ijnm.ijnm_134_20 · 2021
The Utility of PET/CT Metabolic Parameters Measured Based on Fixed Percentage Threshold of SUVmax and Adaptive Iterative Algorithm in the New Revised FIGO Staging System for Stage III Cervical Cancer
2021
Intratumoral heterogeneity as measured using the tumor-stroma ratio and PET texture analyses in females with lung adenocarcinomas differs from that of males with lung adenocarcinomas or squamous cell carcinomas
10.1097/md.0000000000014876 · 2019
Association Between Younger Age and Targetable Genomic Alterations and Prognosis in Non–Small-Cell Lung Cancer
2016
Characteristics of Lung Cancer in Patients Younger than 40 Years: A Prospective Multicenter Analysis in France
10.1159/000489784 · 2018
Clinical and Imaging Features of Non–Small-Cell Lung Cancer in Young Patients
10.1016/j.cllc.2020.10.012 · 2021
Molecular features and clinical outcome of lung malignancies in very young people
10.2217/fon.15.10 · 2015
Clinical Characterization of Node-Negative Lung Adenocarcinoma: Results of a Prospective Investigation
10.1016/s1556-0864(15)30412-3 · 2006
Correlation between FDG-PET/CT findings and solid type non-small cell cancer prognostic factors: are there differences between adenocarcinoma and squamous cell carcinoma?
10.1007/s12149-015-1025-z · 2015
Correlation of quantified metabolic activity in nonsmall cell lung cancer with tumor size and tumor pathological characteristics
10.1097/md.0000000000011628 · 2018
Relationship between primary lesion FDG uptake and clinical stage at PET–CT for non-small cell lung cancer patients: An observation
10.1016/j.lungcan.2009.07.009 · 2010
Stability of radiomic features of apparent diffusion coefficient (ADC) maps for locally advanced rectal cancer in response to image pre-processing
10.1016/j.ejmp.2019.04.009 · 2019
Association of Fluorodeoxyglucose Positron Emission Tomography Radiomics Features with Clinicopathological Factors and Prognosis in Lung Squamous Cell Cancer
10.1007/s13139-022-00774-2 · 2022
Shape and texture analyses based on conventional MRI for the preoperative prediction of the aggressiveness of pituitary adenomas
10.1007/s00330-023-09412-7 · 2023
Comprehensive 18F-FDG PET-based radiomics in elevating the pathological response to neoadjuvant immunochemotherapy for resectable stage III non-small-cell lung cancer: A pilot study
2022
Use of radiomics based on 18F-FDG PET/CT and machine learning methods to aid clinical decision-making in the classification of solitary pulmonary lesions: an innovative approach
10.1007/s00259-021-05220-7 · 2021
Usefulness of gradient tree boosting for predicting histological subtype and EGFR mutation status of non-small cell lung cancer on 18F FDG-PET/CT
10.1007/s12149-019-01414-0 · 2020
Correction to: Machine learning based on clinico-biological features integrated 18F-FDG PET/CT radiomics for distinguishing squamous cell carcinoma from adenocarcinoma of lung
10.1007/s00259-021-05226-1 · 2021
A subregion-based positron emission tomography/computed tomography (PET/CT) radiomics model for the classification of non-small cell lung cancer histopathological subtypes
10.21037/qims-20-1182 · 2021
Machine Learning methods for Quantitative Radiomic Biomarkers
10.1038/srep13087 · 2015
Three-Dimensional Convolutional Neural Network-Based Prediction of Epidermal Growth Factor Receptor Expression Status in Patients With Non-Small Cell Lung Cancer
2022
A novel machine learning method for multiaxial fatigue life prediction: Improved adaptive neuro-fuzzy inference system
10.1016/j.ijfatigue.2023.108007 · 2024
Classification of Pulmonary Nodules in 2-[18F]FDG PET/CT Images with a 3D Convolutional Neural Network
10.1007/s13139-023-00821-6 · 2024
No additional external references are available.